%0 Journal Article
%T Antibody-drug conjugate development: opening windows for EGFR-mutant EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancers?
%A Hida, Toyoaki
%J Translational Lung Cancer Research
%D 2024
%B 2024
%9 
%! Antibody-drug conjugate development: opening windows for EGFR-mutant EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancers?
%K 
%X 
%U https://tlcr.amegroups.org/article/view/85267
%V 13
%N 4
%P 936-939
%@ 2226-4477